Regence offers coverage to meet the costs associated with H1N1

NewsGuard 100/100 Score

To remove financial barriers associated with administration of the H1N1 vaccine and to encourage members to seek vaccination, Regence BlueCross BlueShield will provide coverage for the costs associated with the administration of the H1N1 vaccine during the 2009-2010 flu season, waiving co-pays and deductibles for all members covered by its insured plans. Regence will strongly encourage self-insured employers to cover the full cost to ensure that the greatest number of people are protected.

Working to prevent and contain the spread of H1N1 is an important priority at Regence. This includes educating members on facts about the virus, prevention of illness and information on the vaccine.

Regence will coordinate its efforts with state and federal authorities to ensure the widest possible administration of the vaccine in an effort to mitigate the potential consequences of an H1N1 pandemic.

Based on its analysis of the current situation, The CDC's Advisory Committee on Immunization Practices has recommended prioritizing the following population segments to receive the vaccine:

  • pregnant women
  • caregivers for children younger than 6 months of age
  • health care and emergency medical services personnel
  • children and young adults from 6 months through 24 years old
  • persons aged 25 through 64 years who have underlying health conditions that might increase their risk for flu-related complications

There are steps everyone can take to prepare. Keep a supply of food and medicines on hand in case you have to stay home, and practice good public health measures like frequent hand washing and staying home when sick. For more good information, visit one or more of the following resources:

Source: http://www.regence.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nigeria first to rollout new Men5CV vaccine against meningitis